Clinical Trial Update: Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether armodafinil improves cognition in adults with schizophrenia or schizoaffective disorder; the study has been completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Northwestern University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2025-08-05